MDLN - CIK 0002046386
Medline Inc. trades as MDLN and has a market capitalization of $49.12 B, making it the #322 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $28.43B, up 11.5% from the prior year and net income of $1.16T. This page tracks Medline Inc. through 103 SEC filings, with financial statements and metrics updated as new reports are filed.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| EFFECT | - | 2026-05-21 |
| S-1MEF | - | 2026-05-21 |
| IPO registration | S-1 | 2026-05-20 |
| SCHEDULE 13G/A | - | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| SCHEDULE 13G/A | - | 2026-05-06 |
| SCHEDULE 13G/A | - | 2026-05-01 |
Medline is not selling any shares of Class A common stock in the offering and will not receive any of the proceeds from the sale.
Medline is not selling any shares of Class A common stock in the offering and will not receive any of the proceeds from the sale.
Adjusted EBITDA 1 of $776 million, a decrease of 10.6%
Information about Medline’s financial results, including a link to the live webcast, will be available on the Events page of Medline’s Investor Relations website at ir.medline.com . A replay of the webcast will be available following the event through the same website.
Medline did not sell any shares of Class A common stock in the offering and did not receive any of the proceeds from the sale.
The largest companies sharing Medline Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
Medline Inc. (MDLN) has a market capitalization of $49.12 B as of 2026-05-29, ranking #322 among US-listed companies.
Medline Inc. reported revenue of $28.43B for fiscal year 2025, an increase of 11.5% year over year.
Yes. Medline Inc. reported net income of $1.16T in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.